Living standards in the United States increasingly depend on the competitiveness of industries that compete internationally. The life-science sector, which includes pharmaceuticals, biotechnology, and medical devices, is one of those industries. However, as Joe Kennedy writes for Stat News, the continued health of the U.S. life-sciences sector is at risk because a growing number of foreign competitors are making determined efforts to gain global market share, often using unfair tactics. Any effective U.S. life-sciences innovation policy needs to make leveling the global playing field a top priority, which means taking more forceful action to address unfair trade practices that harm the industry and the jobs it supports.
